
Zydus launches Denosumab biosimilar ‘Zyrifa’ to treat bone complications in cancer patients
The drug maker on Tuesday, December 9, said its wholly-owned subsidiary, Zydus Lifesciences Global FZE, United Arab Emirates, entered into a strategic partnership with Formycon…








